Unless a catastrophic event occurs within the next 4 days sending the markets into a downward spiral, 2010 is going to end on a positive note. With the Dow Jones Industrial Average up 14% YTD many investors are pleased with the how well there portfolio’s have performed. But what steps are you taking... Read more
Posts Tagged ‘2011 Outlook’
Are The Big Drug Companies Still Good Value?
December 13 | Posted by Kevin Monaghan | Top Story Tags: 2011 Outlook, BMY, Bristol-Myers Squibb, Crucell, CRXL, Drug Companies, GENZ, Genzme, Goldman Sachs, GS, JNJ, Johnson & Johnson, Legg Mason, LM, Merck, MRK, PFE, Pfizer, Pharmaceuticals, Sanofi-Aventis, SNY, Value, Value StocksThe Big Pharmaceutical companies have had a slow going year. Many of them are trading right where they started in 2010 or even lower. Although there have been winners such as Genzyme (GENZ), who received a bid from Sanofi-Aventis (SNY) and now trades near $70 after starting the year under $50, most of... Read more




